Liver Injury
The CXCR3 ligand I-TAC correlates with chronic hepatitis C-related inflammation
Published in Hepatitis Weekly, July 5th, 2004
According to recent research from Australia, "the factors that regulate lymphocyte traffic in chronic hepatitis C (CHC) are not completely defined. Interferon (IFN)-inducible T cell alpha chemoattractant (I-TAC) is a relatively new member of the CXCR3 chemokine ligand family that selectively recruits activated T cells to sites of inflammation. To determine if I-TAC plays a role in CHC, we investigated I-TAC expression in hepatitis C virus (HCV)-infected liver biopsy material."
"I-TAC messenger RNA (mRNA) levels were significantly increased in HCV-infected liver compared...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-07-05)
More Articles from Hepatitis Weekly
- Adverse Drug Effects
Severe infections plague acute alcoholic hepatitis patients given infliximab - Chronic Liver Disease
Steatosis exacerbates liver injury in patients with chronic hepatitis C - Hepatology
Insulin resistance helps predict chronic hepatitis C-related liver fibrosis - Immunology
CD8+ T-cell expansion impedes interferon's efforts against hepatitis C virus - Liver Transplantation
Intramuscular hepatitis B immunoglobulin offers advantages to liver recipients - Addiction Medicine
Zinc controls nuclear factor-kappa B activation to protect against liver injury - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
